Griffith Peter H. 4
4 · AMGEN INC · Filed May 9, 2024
Insider Transaction Report
Form 4
AMGEN INCAMGN
Griffith Peter H.
EVP & CFO
Transactions
- Award
Common Stock
2024-05-07+3,196→ 35,973 total - Award
Nqso (Right to Buy)
2024-05-07$300.30/sh+20,767$6,236,330→ 20,767 totalExercise: $300.30From: 2026-05-07Exp: 2034-05-07→ Common Stock (20,767 underlying)
Footnotes (4)
- [F1]The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 5/7/2026, 5/7/2027 and 5/7/2028, respectively.
- [F2]These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 1,135 RSUs which will vest on 4/30/2025; 2,611 RSUs which will vest in installments of 1,286 on 5/2/2025, and one installment of 1,325 on 5/2/2026; 3,814 RSUs which will vest in installments of 1,258 on 5/2/2025, 1,259 on 5/2/2026 and 1,297 on 5/2/2027; and 3,196 RSUs which will vest in installments of 1,054 on 5/7/2026, 1,055 on 5/7/2027, and 1,087 on 5/7/2028. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
- [F3]These shares include 426 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional amount.
- [F4]These non-qualified stock options are exercisable in three installments of 33%, 33% and 34% on 5/7/2026, 5/7/2027 and 5/7/2028, respectively.